These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 25726443)

  • 21. Pharmacodynamics of levofloxacin in a murine pneumonia model of Pseudomonas aeruginosa infection: determination of epithelial lining fluid targets.
    Louie A; Fregeau C; Liu W; Kulawy R; Drusano GL
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3325-30. PubMed ID: 19364849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous Semimechanistic Population Analyses of Levofloxacin in Plasma, Lung, and Prostate To Describe the Influence of Efflux Transporters on Drug Distribution following Intravenous and Intratracheal Administration.
    Zimmermann ES; Laureano JV; Dos Santos CN; Schmidt S; Lagishetty CV; de Castro WV; Dalla Costa T
    Antimicrob Agents Chemother; 2016 Feb; 60(2):946-54. PubMed ID: 26621623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levofloxacin penetration into epithelial lining fluid as determined by population pharmacokinetic modeling and monte carlo simulation.
    Drusano GL; Preston SL; Gotfried MH; Danziger LH; Rodvold KA
    Antimicrob Agents Chemother; 2002 Feb; 46(2):586-9. PubMed ID: 11796385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase 1 study assessing the steady-state concentration of ceftazidime and avibactam in plasma and epithelial lining fluid following two dosing regimens.
    Nicolau DP; Siew L; Armstrong J; Li J; Edeki T; Learoyd M; Das S
    J Antimicrob Chemother; 2015 Oct; 70(10):2862-9. PubMed ID: 26133566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of piperacillin exposure in the lungs of critically ill patients and healthy volunteers.
    Felton TW; Ogungbenro K; Boselli E; Hope WW; Rodvold KA
    J Antimicrob Chemother; 2018 May; 73(5):1340-1347. PubMed ID: 29385448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
    Blasi F; Schaberg T; Centanni S; Del Vecchio A; Rosignoli MT; Dionisio P
    Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution characteristics of orally administered olamufloxacin, a newly synthesized fluoroquinolone antibacterial, in lung epithelial lining fluid and alveolar macrophage in rats.
    Sun J; Deguchi Y; Tauchi Y; He Z; Cheng G; Morimoto K
    Eur J Pharm Biopharm; 2006 Oct; 64(2):238-45. PubMed ID: 16875808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of bacterial kill when modelling the bronchopulmonary pharmacokinetic profile of moxifloxacin and levofloxacin against parC-containing isolates of Streptococcus pneumoniae.
    Deryke CA; Du X; Nicolau DP
    J Antimicrob Chemother; 2006 Sep; 58(3):601-9. PubMed ID: 16857688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Penetration of Antibacterial Agents into Pulmonary Epithelial Lining Fluid: An Update.
    Drwiega EN; Rodvold KA
    Clin Pharmacokinet; 2022 Jan; 61(1):17-46. PubMed ID: 34651282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of clarithromycin in bronchial epithelial lining fluid.
    Kikuchi E; Yamazaki K; Kikuchi J; Hasegawa N; Hashimoto S; Ishizaka A; Nishimura M
    Respirology; 2008 Mar; 13(2):221-6. PubMed ID: 18339019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
    Stein GE; Wells EM
    Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Permeability and concentration of levofloxacin in epithelial lining fluid in patients with lower respiratory tract infections.
    Zhang J; Xie X; Zhou X; Chen YQ; Yu JC; Cao GY; Wu XJ; Shi YG; Zhang YY
    J Clin Pharmacol; 2010 Aug; 50(8):922-8. PubMed ID: 20035039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg.
    Martinez FJ; Grossman RF; Zadeikis N; Fisher AC; Walker K; Ambruzs ME; Tennenberg AM
    Eur Respir J; 2005 Jun; 25(6):1001-10. PubMed ID: 15929954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative determination of unbound levofloxacin by simultaneous microdialysis in rat pancreas after intravenous and oral doses.
    Liu D; Xu S; Xiao H; Wang Z; Mao N; Zhou J; Liu R; Huang Y
    J Pharm Pharmacol; 2014 Sep; 66(9):1215-21. PubMed ID: 24961375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrapulmonary pharmacokinetics and pharmacodynamics of meropenem.
    Conte JE; Golden JA; Kelley MG; Zurlinden E
    Int J Antimicrob Agents; 2005 Dec; 26(6):449-56. PubMed ID: 16280244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioavailability and pharmacokinetic profile of levofloxacin following intravenous, intramuscular and oral administration in turkeys.
    Aboubakr M; Uney K; Elmas M
    Br Poult Sci; 2014 Feb; 55(1):115-9. PubMed ID: 24735473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pilot study testing whether concentrations of levofloxacin in interstitial space fluid of soft tissues may serve as a surrogate for predicting its pharmacokinetics in lung.
    Zeitlinger MA; Traunmüller F; Abrahim A; Müller MR; Erdogan Z; Müller M; Joukhadar C
    Int J Antimicrob Agents; 2007 Jan; 29(1):44-50. PubMed ID: 17189094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study of pharmacokinetics/pharmacodynamics of levofloxacin].
    Zhang J; Yu JC; Shi YG; Zhou L; Ye XY; Zhu DM; Zhang YY
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1926-32. PubMed ID: 16255991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo measurement of levofloxacin penetration into lung tissue after cardiac surgery.
    Hutschala D; Skhirtladze K; Zuckermann A; Wisser W; Jaksch P; Mayer-Helm BX; Burgmann H; Wolner E; Müller M; Tschernko EM
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5107-11. PubMed ID: 16304179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steady-state plasma and bronchopulmonary characteristics of clarithromycin extended-release tablets in normal healthy adult subjects.
    Gotfried MH; Danziger LH; Rodvold KA
    J Antimicrob Chemother; 2003 Sep; 52(3):450-6. PubMed ID: 12888589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.